Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

  

Search in our Online Store
Vaccines
Filter     Order     Display # 
Date Item Title
29 Mar 2007 Oxford BioMedica and Sanofi-Aventis Enter Global Licensing Agreement to Develop and Commercialise TroVax for Cancer
22 Mar 2007 Acambis PLC (ACAM) is First Company to Test a West Nile Virus Vaccine in Older Adults
21 Mar 2007 GenVec Signs Cooperative Research and Development Agreement (CRADA) with the National Institute of Allergy and Infectious Diseases (NIAID) to Develop RSV Vaccines
16 Mar 2007 British doctors to start new phase III trial with Pharmexa's GV1001
15 Mar 2007 immatics granted orphan drug status for therapeutic cancer vaccine IMA901
15 Mar 2007 Prima Biomed Final Phase IIa Results for Ovarian Cancer Treatment Exceeded Expectations
15 Mar 2007 Novel tuberculosis vaccine shows promising immunogenicity and safety profile
14 Mar 2007 Placebo-controlled Phase IIa Study with the Immunotherapeutic CYT003-QbG10 Shows Significant Improvement of Allergy Symptoms in Hay Fever Patients
13 Mar 2007 Preclinical Update – Debio-0512 Therapeutic Vaccine For The Treatment Of Chronic And Acute Inflammatory Conditions
10 Mar 2007 Curalogic has started clinical EU phase III trial with its ragweed product
09 Mar 2007 Diamyd Medical Announces Phase III Clinical Trials Plan For Diamyd(R) In Type 1 Diabetes
06 Mar 2007 Nventa Announces Presentation Of Positive HSPE7 Data From Nci-Sponsored Clinical Trial In Cervical Dysplasia
06 Mar 2007 Iomai Vaccine for Travelers' Diarrhea Blunts Severity of Disease in Clinical Study
06 Mar 2007 New studies indicate GSK's pre-pandemic influenza vaccine can protect against different strains of H5N1
02 Mar 2007 European Committee Issued Positive Opinions to Extend Indication for PREVENAR to Include Pneumonia and Otitis Media
02 Mar 2007 Dynavax Initiates Phase I Trial of Hepatitis B Therapy
02 Mar 2007 Genelabs Announces Publication In New England Journal Of Medicine Of Clinical Trial Results With Hepatitis E Virus Vaccine
02 Mar 2007 Acambis’ JE vaccine meets and exceeds primary endpoint in pivotal Phase 3 efficacy trial
01 Mar 2007 Phase I Data From Targeted Genetics' tgAAC09 Vaccine for HIV/AIDS Presented at Scientific Conference
27 Feb 2007 Merck KGaA: Stimuvax Cancer Vaccine Phase III Study Begins
24 Feb 2007 Focetria(R) pandemic influenza vaccine receives positive European Union regulatory agency opinion supporting approval
24 Feb 2007 Dynavax Reports Interim, One-Year Data From Ragweed Allergy Trial at AAAAI
23 Feb 2007 Cell Genesys and Medarex Announce Encouraging Follow-Up Results from a Phase 1 Combination Therapy Trial With GVAX Immunotherapy for Prostate Cancer and Ipilimumab (MDX-010) Antibody
22 Feb 2007 Pre-Clinical Study of Novavax's Seasonal Influenza Vaccine Published in Journal 'Vaccine'
20 Feb 2007 New Data Support Alphavax's Vaccine For CMV
16 Feb 2007 The Immune Response Corporation's Interim Phase II Data Suggest Both REMUNE and IR103 Stabilize CD4+ Cell Counts in Drug-Naive HIV Patients
15 Feb 2007 Acambis signs JE partnership agreement with sanofi pasteur
15 Feb 2007 Study Published in The New England Journal of Medicine: 55 Percent Fewer Cases of Flu in Young Children Vaccinated With FluMist(R) Vs. Flu Shot
14 Feb 2007 First Patients Undergo Surgery in Northwest Biotherapeutics' Phase II Brain Cancer Trial
14 Feb 2007 Transgene Initiates A Phase I Trial of its Therapeutic Vaccine Candidate TG4040 for Patients Chronically Infected With the Hepatitis C Virus
13 Feb 2007 Favrille Announces Long-Term Follow-Up Data From Phase 2 Clinical Trial of FavId Following Autologous Stem Cell Transplantation for B-Cell Non-Hodgkin's Lymphoma
13 Feb 2007 AVANT Immunotherapeutics and Select Vaccines Announce Partnership to Develop Improved Viral Vaccines
10 Feb 2007 Personalized Immunotherapy Clinical Trial Initiated in HIV Patients with Argos Therapeutics' AGS-004
09 Feb 2007 Africa's First Large-Scale HIV Vaccine Study Launches
06 Feb 2007 Human Trial Results Show Excellent Safety Data, Positive Immune Responses From GeoVax's DNA/MVA AIDS Vaccines
02 Feb 2007 Generex Biotechnology to Initiate Phase II Clinical Trials in Breast Cancer Patients in Collaboration with United States Military's Cancer Institute
01 Feb 2007 B-Cell Chronic Lymphocytic Leukemia Clinical Trial Initiated with Argos Therapeutics’ AGS-005 Personalized Immunotherapy
30 Jan 2007 Introgen's INGN 225 Molecular Cancer Vaccine Demonstrates Promising Results in Phase 2 Trial
30 Jan 2007 GlaxoSmithKline files its new pre-pandemic influenza vaccine in Europe
30 Jan 2007 Alphavax Announces Clinical Trials For Influenza And Cmv
27 Jan 2007 Placebo-controlled phase IIa study with hypertension vaccine CYT006-AngQb shows reduction in day-time blood pressure
27 Jan 2007 Crucell's PER.C6(R)-based West Nile Vaccine Demonstrates Excellent Safety and Tolerability
26 Jan 2007 FDA Advisory Committee Recommends Licensure Of New Pediatric Combination Vaccine
24 Jan 2007 Commencement of Pollinex(R) Quattro Grass Dosing.
23 Jan 2007 Cell Genesys Announces Encouraging Follow-Up Survival Data From Phase 2 Clinical Trial of GVAX(R) Immunotherapy for Pancreatic Cancer
20 Jan 2007 BioMS Medical Cleared By FDA To Initiate Pivotal Phase III Multiple Sclerosis Trial
19 Jan 2007 GlaxoSmithKline initiates head-to-head study of cervical cancer vaccines
18 Jan 2007 First Malaria Vaccine Trial Launched Under GenVec/U.S. Navy Collaboration
18 Jan 2007 Acambis receives Complete Response Letter from FDA on ACAM2000 Biologics Licence Application
17 Jan 2007 Dendreon's PROVENGE Granted FDA Priority Review for the Treatment of Asymptomatic, Metastatic, Androgen-Independent Prostate Cancer
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Results 301 - 350 of 591

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Thrombopoiesis-Stimulating Agents (TPO)

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics